HPV Testing and Pap Test Market Outlook (2022 to 2032)
The global HPV Testing and Pap Test Market was valued at around US$ 2.2 Billion in 2021. With a projected CAGR of 19.3% for the next ten years, the market is likely to reach a valuation of approximately US$ 15 Billion by the end of 2032.
Attributes
Details
HPV Testing and Pap Test Market Size (2021A)
US$2.2 Billion
Estimated Market Value (2022E)
US$2.6 Billion
Forecasted Market Value (2032)
US$15 Billion
Global Market Growth Rate (2022 to 2032)
19.3% CAGR
United States Forecasted Market Value (2032)
US$ 5.9 Billion
USA Growth Rate(2022 to 2032)
20.4% CAGR
Key Companies Covered
Abbott Laboratories, Qiagen N.V.
Becton, Dickinson, and Company
Quest Diagnostics, Inc.
Hologic, Inc.
F. Hoffmann-La Roche
Femasys, Inc.
Arbor Vita Corporation
NURX, Inc.
Seegene, Inc.
Thermo Fisher Scientific. Inc.
bioMérieux SA
Future Market Insights’ analysis reveals that most of the HPV Testing and Pap Test market revenue are grossed from Pap Tests, which have a predicted CAGR of 16.8% by 2032. Cervical Cancer Screening is the top application of these tests, with a CAGR of 18.4% in the forecast period. HVC and Pap tests are used extensively in Cervical Cancer Screening and awareness drives, government policies, and programs provide a significant demand boost.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales Analysis of HVC and Pap tests 2015 to 2021 Vs Market Outlook for 2022 to 2032
The global HPV Testing and Pap Test market expanded at a CAGR of 17.2% from 2015 to 2021. The global market is predicted to surge ahead at a CAGR of 19.3% and record sales worth US$ 15 Billion by the end of 2032, registering an absolute dollar opportunity of US$ 12 Billion from 2022 to 2032.
Which factors are driving the demand for HVC and Pap Tests?
Cervical cancer is the 4th most common form of cancer amongst women worldwide. In 2020, there were an estimated 604,000 new cases and 342,000 related deaths. Cervical cancer is most treatable and curable if vaccinations are effective and the cancer is detected at an early stage and proper treatment is given promptly.
If detected at an early stage, the 5-year survival rate is very high at around 92%. Even cancers at later stages can be managed with proper treatment and care. The global strategy for cervical cancer elimination, endorsed by the WHO in 2020, aims for 70% of women globally to have undergone testing at regular intervals by 2030.
The policy is based on the idea that implementing this, along with other policies regarding treatment and vaccination could eliminate cervical cancer deaths in a century. According to the WHO, this could prevent around 62 million deaths. Pap testing, which tests for cell changes that could potentially be or become cervical cancer, and HPV testing, which looks for high-risk HPV are globally recommended. In recent years, demand is increasing due to increased awareness, developments in reducing costs, and government policies and programs.
Find your sweet spots for generating winning opportunities in this market.
How have government policies and drives affected the HPV Testing and Pap Test market?
There have been a number of government programs and policies that are boosting the global demand for testing. In the USA, the CDC recommends a Pap test or cytology test once every 3 years for 21-29-year-olds and a pap test every 3 years or an HPV test every 5 years, or a cotest of both Pap and HPV tests every 5 years for those over 30 years.
In China, the All-China Women's Federation and the Ministry of Health launched a dual program for screening cervical and breast cancer in rural women, at 3-year intervals. In Japan, the National Cancer Center recommends screening every 2 years. Most cities offer free or subsidized options for women of eligible age groups. In South Korea, which has a single-payer public health insurance system, eligible women over 20 years of age are provided a free screening once every 2 years.
How have new technologies in product type and technological advancements affected the HPV Testing and Pap Test market in low-resource countries?
Nearly 90% of HPV deaths occurring in 2020, occurred in low and middle-income countries; largely owing to the fact that low-resource areas often do not have the ability to provide regular screening. A commonly used method is Visual Inspection with Acetic Acid or VIA testing which involves a health worker applying dilute acetic acid to the cervix and inspecting it for visual signs of whitening with the naked eye.
This method is used despite lower accuracy in low-resource areas since it has lower cost-per-test and is convenient. Another developing technology that has the potential to raise demand in low-resource areas is the use of AI in diagnosis. A team of researchers from the National Cancer Institute (NCI) and Global Good trained an ML algorithm to use Automated Visual Evaluation (AVE) to analyze images of a cervix and identify changes that could lead to cancer. The images can be taken with even a simple camera. New developments such as training the algorithm with a more global set of images to account for geographic variations are expected to eventually raise demand.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
What is the top application of HPV Testing and Pap Tests?
Cervical Cancer Screening is the top application for HPV testing and Pap Testing, with a CAGR of 16.7% from 2015 to 2021. The forecasted CAGR for this category is 18.4% for the period 2022 to 2032. Neither HPV testing nor the Pap test can detect vaginal cancer on its own, but they do detect cervical cancer and pre-cancerous conditions- which are often precursors to vaginal cancer, and HPV, which increases the risk of developing vaginal cancer.
Region-Wise Insights
How is Europe an emerging market for demand?
Europe is an emerging HPV Testing and Pap Test market for HPV and Pap tests. According to the European Centre for Disease Prevention and Control or the ECDC, 2.5% of all cancers in Europe are caused by HPV, and Cervical cancer is the second most common type of cancer in women of the 15 to 55 age group, after only breast cancer. Awareness drives and official programs are driving demand. For example, in the United Kingdom, the NHS provides free tests to women every 3 years if in the 25 to 29 age category and every 5 years to women over 50 years of age. The program uses an initial HPV test and an additional Pap Test for cells that test positive.
Country-wise Insights
USA HPV Testing and Pap Test Market Analysis
The USA contributes significantly to the HPV and Pap Tests market, with a forecasted market size of US $5.9 Billion by 2032. The American cancer society recommends screening with an HPV test or HPV/Pap cotest every 5 years from 25 years of age to 65 years, or a Pap Test every 3 years. The Centers for Disease Control provides free or low-cost screenings to women who qualify based on factors like income levels and insurance coverage under their National Breast and Cervical Cancer Early Detection Program (NBCCEDP). The HPV Testing and Pap Test market in the country is expected to garner an absolute dollar opportunity of US$ 5 Billion. The HPV Testing and Pap Test market in the USA witnessed a CAGR of 18.2% from 2015 to 2021 and is expected to continue growing, with a forecasted CAGR growing at 20.4%.
United Kingdom HPV Testing and Pap Test Market Analysis
The HPV Testing and Pap Test market in the United Kingdom is expected to reach a valuation of US$ 672.7 Million by 2032. With a projected CAGR of 20.2% from 2022 to 2032, the market is expected to garner an absolute dollar opportunity of US$ 567 Million.
Japan HPV Testing and Pap Test Market Analysis
The HPV Testing and Pap Test market in Japan is expected to account for US$ 795 Million by 2032. Growing at a CAGR of 22.4% from 2022 to 2032, the market is likely to gross an absolute dollar opportunity of US$ 689 Million.
South Korea HPV Testing and Pap Test Market Analysis
The HPV Testing and Pap Test market in South Korea is expected to reach a valuation of US$ 241 Million by 2032. The market from 2022 to 2032 is expected to grow at a CAGR to garner an absolute dollar opportunity of US$ 194 Million.
Category-wise Insights
Why are Pap Tests the key contributors to revenue?
PAP tests are the largest contributor to HPV Testing and Pap Test market revenue, having witnessed a CAGR of 16.8% with a forecasted CAGR of 17.5% for the next decade. Their use has led to a significant decrease in Cervical Cancer deaths. However, new WHO guidelines shift to the HPV DNA-based test as preferred over the currently prevalent VIA or Pap Tests. Despite this, Pap tests, which are the historical method in use, are still useful and common. There are concerns that additional HPV testing would mean an increase in invasive procedures. A combination of both tests is now recommended, with healthcare providers and global programs choosing whether to administer one of the two or both depending on patient age, history, and availability of resources.
Competitive Landscape
HPV Testing and Pap Test providers are focused on increasing the efficiency, accuracy, and affordability of their tests and harnessing new technology. The key companies operating include Abbott Laboratories, Qiagen N.V., Becton, Dickinson and Company, Quest Diagnostics, Inc., Hologic, Inc., F. Hoffmann-La Roche, Femasys, Inc., Arbor Vita Corporation, NURX, Inc., Seegene, Inc., Thermo Fisher Scientific. Inc., and bioMérieux SA
Some of the recent developments in HPV Testing and Pap Tests are as follows:
In June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare pharmaceutical and diagnostics company announced the launch of a self-sampling solution, via which patients can collect samples privately at a healthcare facility under instructions and have them analyzed. The aim of enabling self-collection was to provide an alternative to the usual invasive clinician-based collection process.
In May 2022, Alercell, Inc, a molecular diagnostics company and provider of diagnostics announced its HPV DNA-based test kit: Meltpro HPV genotype test. It is based on DNA sequencing analysis. The use of a PCR machine eliminates the risk of human interpretation and provides faster results, taking under three hours.
In June 2022, Operating in the oncology healthcare sector, Karkinos Healthcare developed CerviRaksha, a clinically validated HPV test, pre-qualified and approved by the World Health Organization (WHO) and the United States Food and Drug Administration (FDA). It was also granted the CE mark and bears the CE mark. Samples are collected at home and results are provided by email. The HPV-16 and HPV-18 genotypes are distinguished individually, and false positives are filtered.
In May 2022, The London School of Hygiene and Tropical Medicine and the University of Manchester, and the University of Hull will collaborate to test for cervical cancer in women of the 65-and-older age group, who are often overlooked despite accounting for over 50% of cervical cancer incidents in the United Kingdom. This test will also only require a urine sample, which might encourage women who were opting out of the test to take part.
Similarly, recent developments related to companies manufacturing HPV Testing and Pap Tests have been tracked by the team at Future Market Insights, which is available in the full report.
Key Segments Covered in HPV Testing and Pap Test Survey
HPV Testing and Pap Test Market by Type:
HPV Testing
Pap Test
HPV Testing and Pap Test Market by Application:
Vaginal Cancer Screening
Cervical Cancer Screening
HPV Testing and Pap Test Market by Product Type:
Instruments
Consumables
Services
HPV Testing and Pap Test Market by Technology:
PCR
Immunodiagnostics
Other Technologies
HPV Testing and Pap Test Market by Region:
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Frequently Asked Questions
How much is the global HPV Testing and Pap Test Market currently worth?
The global HPV Testing and Pap Test market was valued at US$ 2.2 Billion in 2021.
What is the HPV Testing and Pap Test market Forecast through 2032?
The HPV Testing and Pap Test industry is set to witness a growth rate of 19.3% over the forecast period and be valued at US$ 15 Billion by 2032.
At what rate did demand for HPV Testing and Pap Test increase over the past years?
The HPV Testing and Pap Test market expanded by 17.2% from 2015 through 2021.
Who are the key players shaping the HPV Testing and Pap Test Industry?
Abbott Laboratories, Qiagen N.V., Becton, Dickinson and Company, Quest Diagnostics, Inc., Hologic, Inc., F. Hoffmann-La Roche, Femasys, Inc., Arbor Vita Corporation, NURX, Inc., Seegene, Inc., Thermo Fisher Scientific. Inc., bioMérieux SA are some of the key players in the market.
Who are the top 5 countries driving the highest sales of HPV Testing and Pap Test ?
The USA, United Kingdom, China, Japan, and South Korea are expected to be the key drivers of sales.
What is the USA market outlook for HPV Testing and Pap Test ?
The market in the USA accounts for over 39% of the global market.
Table of Content
1. Executive Summary | HPV Testing and Pap Test Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2015 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2015 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Test Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2015 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2022 to 2032
5.3.1. HPV Testing
5.3.2. Pap Test
5.4. Y-o-Y Growth Trend Analysis By Test Type, 2015 to 2021
5.5. Absolute $ Opportunity Analysis By Test Type, 2022 to 2032
6. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2015 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032
6.3.1. Vaginal Cancer Screening
6.3.2. Cervical Cancer Screening
6.4. Y-o-Y Growth Trend Analysis By Application, 2015 to 2021
6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
7. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2015 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032
7.3.1. Instruments
7.3.2. Consumables
7.3.3. Services
7.4. Y-o-Y Growth Trend Analysis By Product Type, 2015 to 2021
7.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Technology
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2015 to 2021
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2022 to 2032
8.3.1. PCR (Polymerase Chain Reaction)
8.3.2. Immunodiagnostics
8.3.3. Other Technologies
8.4. Y-o-Y Growth Trend Analysis By Technology, 2015 to 2021
8.5. Absolute $ Opportunity Analysis By Technology, 2022 to 2032
9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2015 to 2021
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Test Type
10.2.3. By Application
10.2.4. By Product Type
10.2.5. By Technology
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Type
10.3.3. By Application
10.3.4. By Product Type
10.3.5. By Technology
10.4. Key Takeaways
11. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Test Type
11.2.3. By Application
11.2.4. By Product Type
11.2.5. By Technology
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test Type
11.3.3. By Application
11.3.4. By Product Type
11.3.5. By Technology
11.4. Key Takeaways
12. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. Italy
12.2.1.3. France
12.2.1.4. United Kingdom
12.2.1.5. Russia
12.2.1.6. BENELUX
12.2.1.7. Rest of Europe
12.2.2. By Test Type
12.2.3. By Application
12.2.4. By Product Type
12.2.5. By Technology
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Test Type
12.3.3. By Application
12.3.4. By Product Type
12.3.5. By Technology
12.4. Key Takeaways
13. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.1.4. Rest of Asia Pacific
13.2.2. By Test Type
13.2.3. By Application
13.2.4. By Product Type
13.2.5. By Technology
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Test Type
13.3.3. By Application
13.3.4. By Product Type
13.3.5. By Technology
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Turkey
14.2.1.4. Rest of Middle East and Africa
14.2.2. By Test Type
14.2.3. By Application
14.2.4. By Product Type
14.2.5. By Technology
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Test Type
14.3.3. By Application
14.3.4. By Product Type
14.3.5. By Technology
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Test Type
15.1.2.2. By Application
15.1.2.3. By Product Type
15.1.2.4. By Technology
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Test Type
15.2.2.2. By Application
15.2.2.3. By Product Type
15.2.2.4. By Technology
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Test Type
15.3.2.2. By Application
15.3.2.3. By Product Type
15.3.2.4. By Technology
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Test Type
15.4.2.2. By Application
15.4.2.3. By Product Type
15.4.2.4. By Technology
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Test Type
15.5.2.2. By Application
15.5.2.3. By Product Type
15.5.2.4. By Technology
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Test Type
15.6.2.2. By Application
15.6.2.3. By Product Type
15.6.2.4. By Technology
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Test Type
15.7.2.2. By Application
15.7.2.3. By Product Type
15.7.2.4. By Technology
15.8. United Kingdom
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Test Type
15.8.2.2. By Application
15.8.2.3. By Product Type
15.8.2.4. By Technology
15.9. Russia
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Test Type
15.9.2.2. By Application
15.9.2.3. By Product Type
15.9.2.4. By Technology
15.10. BENELUX
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Test Type
15.10.2.2. By Application
15.10.2.3. By Product Type
15.10.2.4. By Technology
15.11. China
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Test Type
15.11.2.2. By Application
15.11.2.3. By Product Type
15.11.2.4. By Technology
15.12. Japan
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Test Type
15.12.2.2. By Application
15.12.2.3. By Product Type
15.12.2.4. By Technology
15.13. South Korea
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Test Type
15.13.2.2. By Application
15.13.2.3. By Product Type
15.13.2.4. By Technology
15.14. GCC Countries
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Test Type
15.14.2.2. By Application
15.14.2.3. By Product Type
15.14.2.4. By Technology
15.15. South Africa
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Test Type
15.15.2.2. By Application
15.15.2.3. By Product Type
15.15.2.4. By Technology
15.16. Turkey
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Test Type
15.16.2.2. By Application
15.16.2.3. By Product Type
15.16.2.4. By Technology
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Test Type
16.3.3. By Application
16.3.4. By Product Type
16.3.5. By Technology
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Abbott Laboratories
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Qiagen N.V.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Becton, Dickinson, and Company
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Quest Diagnostics, Inc.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Hologic, Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. F. Hoffmann-La Roche
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Femasys, Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Arbor Vita Corporation
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. NURX, Inc.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Seegene, Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. Thermo Fisher Scientific, Inc.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.12. bioMérieux SA
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
18. Assumptions & Acronyms Used19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2015 to 2032
Table 2: Global Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 3: Global Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 4: Global Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 5: Global Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Table 6: North America Market Value (US$ Million) Forecast by Country, 2015 to 2032
Table 7: North America Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 8: North America Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 9: North America Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 10: North America Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2015 to 2032
Table 12: Latin America Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 13: Latin America Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 14: Latin America Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 15: Latin America Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Table 16: Europe Market Value (US$ Million) Forecast by Country, 2015 to 2032
Table 17: Europe Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 18: Europe Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 19: Europe Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 20: Europe Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Table 21: Asia Pacific Market Value (US$ Million) Forecast by Country, 2015 to 2032
Table 22: Asia Pacific Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 23: Asia Pacific Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 24: Asia Pacific Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 25: Asia Pacific Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Table 26: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2015 to 2032
Table 27: Middle East and Africa Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 28: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 2: Global Market Value (US$ Million) by Application, 2022 to 2032
Figure 3: Global Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 4: Global Market Value (US$ Million) by Technology, 2022 to 2032
Figure 5: Global Market Value (US$ Million) by Region, 2022 to 2032
Figure 6: Global Market Value (US$ Million) Analysis by Region, 2015 to 2032
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 9: Global Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 10: Global Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 11: Global Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 12: Global Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 13: Global Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 14: Global Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 15: Global Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 16: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 17: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 18: Global Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 19: Global Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 20: Global Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 21: Global Market Attractiveness by Test Type, 2022 to 2032
Figure 22: Global Market Attractiveness by Application, 2022 to 2032
Figure 23: Global Market Attractiveness by Product Type, 2022 to 2032
Figure 24: Global Market Attractiveness by Technology, 2022 to 2032
Figure 25: Global Market Attractiveness by Region, 2022 to 2032
Figure 26: North America Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 27: North America Market Value (US$ Million) by Application, 2022 to 2032
Figure 28: North America Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 29: North America Market Value (US$ Million) by Technology, 2022 to 2032
Figure 30: North America Market Value (US$ Million) by Country, 2022 to 2032
Figure 31: North America Market Value (US$ Million) Analysis by Country, 2015 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 34: North America Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 35: North America Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 37: North America Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 40: North America Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 41: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 42: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 43: North America Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 44: North America Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 46: North America Market Attractiveness by Test Type, 2022 to 2032
Figure 47: North America Market Attractiveness by Application, 2022 to 2032
Figure 48: North America Market Attractiveness by Product Type, 2022 to 2032
Figure 49: North America Market Attractiveness by Technology, 2022 to 2032
Figure 50: North America Market Attractiveness by Country, 2022 to 2032
Figure 51: Latin America Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 52: Latin America Market Value (US$ Million) by Application, 2022 to 2032
Figure 53: Latin America Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 54: Latin America Market Value (US$ Million) by Technology, 2022 to 2032
Figure 55: Latin America Market Value (US$ Million) by Country, 2022 to 2032
Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2015 to 2032
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 59: Latin America Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 62: Latin America Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 65: Latin America Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 68: Latin America Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 69: Latin America Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 71: Latin America Market Attractiveness by Test Type, 2022 to 2032
Figure 72: Latin America Market Attractiveness by Application, 2022 to 2032
Figure 73: Latin America Market Attractiveness by Product Type, 2022 to 2032
Figure 74: Latin America Market Attractiveness by Technology, 2022 to 2032
Figure 75: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 76: Europe Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 77: Europe Market Value (US$ Million) by Application, 2022 to 2032
Figure 78: Europe Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 79: Europe Market Value (US$ Million) by Technology, 2022 to 2032
Figure 80: Europe Market Value (US$ Million) by Country, 2022 to 2032
Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2015 to 2032
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 84: Europe Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 85: Europe Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 87: Europe Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 88: Europe Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 90: Europe Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 91: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 93: Europe Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 94: Europe Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 95: Europe Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 96: Europe Market Attractiveness by Test Type, 2022 to 2032
Figure 97: Europe Market Attractiveness by Application, 2022 to 2032
Figure 98: Europe Market Attractiveness by Product Type, 2022 to 2032
Figure 99: Europe Market Attractiveness by Technology, 2022 to 2032
Figure 100: Europe Market Attractiveness by Country, 2022 to 2032
Figure 101: Asia Pacific Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 102: Asia Pacific Market Value (US$ Million) by Application, 2022 to 2032
Figure 103: Asia Pacific Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 104: Asia Pacific Market Value (US$ Million) by Technology, 2022 to 2032
Figure 105: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032
Figure 106: Asia Pacific Market Value (US$ Million) Analysis by Country, 2015 to 2032
Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 112: Asia Pacific Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 115: Asia Pacific Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 118: Asia Pacific Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 121: Asia Pacific Market Attractiveness by Test Type, 2022 to 2032
Figure 122: Asia Pacific Market Attractiveness by Application, 2022 to 2032
Figure 123: Asia Pacific Market Attractiveness by Product Type, 2022 to 2032
Figure 124: Asia Pacific Market Attractiveness by Technology, 2022 to 2032
Figure 125: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 126: Middle East and Africa Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 127: Middle East and Africa Market Value (US$ Million) by Application, 2022 to 2032
Figure 128: Middle East and Africa Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 129: Middle East and Africa Market Value (US$ Million) by Technology, 2022 to 2032
Figure 130: Middle East and Africa Market Value (US$ Million) by Country, 2022 to 2032
Figure 131: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2015 to 2032
Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 135: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 136: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 137: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 138: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 139: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 140: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 141: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 142: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 143: Middle East and Africa Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 144: Middle East and Africa Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 145: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 146: Middle East and Africa Market Attractiveness by Test Type, 2022 to 2032
Figure 147: Middle East and Africa Market Attractiveness by Application, 2022 to 2032
Figure 148: Middle East and Africa Market Attractiveness by Product Type, 2022 to 2032
Figure 149: Middle East and Africa Market Attractiveness by Technology, 2022 to 2032
Figure 150: Middle East and Africa Market Attractiveness by Country, 2022 to 2032
